How much revenue did Lipitor generate before its patent expired?
The amount of money Lipitor (atorvastatin) made before its patent expired isn’t stated in the provided information, and I don’t have access here to the specific revenue figure you’re asking for.
When did Lipitor’s patent/exclusivity end?
Your question depends on which “end” you mean (patent expiration vs. regulatory exclusivity vs. the timing of generic launches). Different dates can change the window for “before it expired,” so the exact total revenue can’t be pinned down without a source tied to the specific endpoint.
What figure would answer “how much money” most precisely?
To produce a defensible number, you’d typically want one of these metrics:
- total annual sales for a defined period ending at the patent-expiration date
- total sales from launch through the patent-expiration date
- cumulative net sales (after discounts/returns), not gross “revenue”
Fast way to get the right number
If you share the specific patent/exclusivity date you mean (or the country/region), I can help map it to the corresponding sales window. If you want, tell me whether you mean:
- U.S. patent expiration, or
- global sales through the period when generics could enter.
Source check (if you meant patent status details)
DrugPatentWatch.com is often used for patent/exclusivity timelines and related IP milestones, but I still need the underlying sales figure source to answer the dollar total you requested. If you want to proceed, tell me your preferred geography (e.g., U.S.) and I’ll align the “before expiration” window accordingly.
Sources
- [1] https://www.drugpatentwatch.com/